Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Jan;23(1):43–45. doi: 10.1128/jcm.23.1.43-45.1986

Involvement of coagulase-negative staphylococci in toxic shock syndrome.

B A Crass, M S Bergdoll
PMCID: PMC268569  PMID: 3700606

Abstract

Coagulase-negative staphylococci that produce toxic shock syndrome toxin 1 (TSST-1) or a staphylococcal enterotoxin or both were isolated from various sources. Coagulase-negative strains that produce TSST-1 alone or with enterotoxin A were the only staphylococci isolated from seven patients with toxic shock syndrome. Two other toxic shock syndrome patients had coagulase-positive staphylococci also, but only the coagulase-negative strains produced TSST-1. Coagulase-positive and coagulase-negative strains that produced TSST-1 were isolated from two other toxic shock syndrome patients. In addition, coagulase-negative staphylococci that produced toxins were isolated from patients with other staphylococcal infections and from food implicated in a case of food poisoning.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altemeier W. A., Lewis S. A., Schlievert P. M., Bergdoll M. S., Bjornson H. S., Staneck J. L., Crass B. A. Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing. Ann Intern Med. 1982 Jun;96(6 Pt 2):978–982. doi: 10.7326/0003-4819-96-6-978. [DOI] [PubMed] [Google Scholar]
  2. Baehler E. A., Dillon W. P., Dryja D. M., Neter E. The effects of prolonged retention of diaphragms on colonization by Staphylococcus aureus of the lower genital tract. Fertil Steril. 1983 Feb;39(2):162–166. doi: 10.1016/s0015-0282(16)46813-5. [DOI] [PubMed] [Google Scholar]
  3. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  4. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Lee A. C., Chesney P. J., Davis J. P., Vergeront J. M., Wand P. J. An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med. 1982 Jun;96(6 Pt 2):969–971. doi: 10.7326/0003-4819-96-6-969. [DOI] [PubMed] [Google Scholar]
  5. Galask R. P., Larsen B., Ohm M. J. Vaginal flora and its role in disease entities. Clin Obstet Gynecol. 1976 Mar;19(1):61–81. doi: 10.1097/00003081-197603000-00008. [DOI] [PubMed] [Google Scholar]
  6. Hovelius B., Mårdh P. A. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis. 1984 May-Jun;6(3):328–337. doi: 10.1093/clinids/6.3.328. [DOI] [PubMed] [Google Scholar]
  7. Koupal A., Deibel R. H. Rapid qualitative method for detecting staphylococcal nuclease in foods. Appl Environ Microbiol. 1978 Jun;35(6):1193–1197. doi: 10.1128/aem.35.6.1193-1197.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lowy F. D., Hammer S. M. Staphylococcus epidermidis infections. Ann Intern Med. 1983 Dec;99(6):834–839. doi: 10.7326/0003-4819-99-6-834. [DOI] [PubMed] [Google Scholar]
  9. Robbins R., Gould S., Bergdoll M. Detecting the enterotoxigenicity of Staphylococcus aureus strains. Appl Microbiol. 1974 Dec;28(6):946–950. doi: 10.1128/am.28.6.946-950.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981 Apr;143(4):509–516. doi: 10.1093/infdis/143.4.509. [DOI] [PubMed] [Google Scholar]
  11. Shands K. N., Schmid G. P., Dan B. B., Blum D., Guidotti R. J., Hargrett N. T., Anderson R. L., Hill D. L., Broome C. V., Band J. D. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980 Dec 18;303(25):1436–1442. doi: 10.1056/NEJM198012183032502. [DOI] [PubMed] [Google Scholar]
  12. Staneck J. L., Bonventre P. F. Toxic shock syndrome: a microbiological perspective. Surv Synth Pathol Res. 1984;3(1):38–53. doi: 10.1159/000156914. [DOI] [PubMed] [Google Scholar]
  13. TURNER F. J., SCHWARTZ B. S. The use of a lyophilized human plasma standardized for blood coagulation factors in the coagulase and fibrinolytic tests. J Lab Clin Med. 1958 Dec;52(6):888–894. [PubMed] [Google Scholar]
  14. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
  15. de Nooij M. P., van Leeuwen W. J., Notermans S. Enterotoxin production by strains of Staphylococcus aureus isolated from clinical and non-clinical specimens with special reference to enterotoxin F and toxic shock syndrome. J Hyg (Lond) 1982 Dec;89(3):499–505. doi: 10.1017/s0022172400071060. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES